PsiOxus is committed to developing our pipeline through the establishment of strategic partnerships with leading immuno-oncology companies and academic groups. We are currently seeking strategic immuno-oncology partners for our gene therapy virus products from our proprietary T-SIGn platform technology, including:

  • Collaborations on PsiOxus’ existing pipeline products
  • Research collaborations to develop novel T-SIGn virus programs including development of novel programs using proprietary partner genes or combinations of genes

For more information or inquiries on collaborations and partnerships, please contact [email protected]


Strategic Collaborations

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image